Adoptive Immunotherapy beyond CAR T-Cells

Adoptive Immunotherapy beyond CAR T-Cells

Adoptive cell immunotherapy (ACT) is a vibrant field of cancer treatment that began progressive development in the 1980s. One of the most prominent and promising examples is chimeric antigen receptor (CAR) T-cell immunotherapy for the treatment of B-cell hematologic malignancies. Despite success in...

Full description

Bibliographic Details
Main Authors:	Aleksei Titov, Ekaterina Zmievskaya, Irina Ganeeva, Aygul Valiullina, Alexey Petukhov, Aygul Rakhmatullina, Regina Miftakhova, Michael Fainshtein, Albert Rizvanov, Emil Bulatov
Format:	Article
Language:	English
Published:	MDPI AG 2021-02-01
Series:	Cancers
Subjects:	chimeric antigen receptor CAR T-cell CAR NK-cell transgeneic TCR TIL neoantigen
Online Access:	https://www.mdpi.com/2072-6694/13/4/743

Similar Items

Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment
by: Aleksei Titov, et al.
Published: (2020-01-01)

Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections
by: Ekaterina Zmievskaya, et al.
Published: (2021-01-01)

Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research
by: Zhidong Wang, et al.
Published: (2020-03-01)

Novel strategies for immuno-oncology breakthroughs with cell therapy
by: Hongtao Liu, et al.
Published: (2021-07-01)

Proceedings From the First International Workshop at Sidra Medicine: “Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development”, 15th–16th February 2019, Doha, Qatar
by: Bella Guerrouahen, et al.
Published: (2021-01-01)

Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine
by: Jesús Fuentes-Antrás, et al.
Published: (2020-10-01)

Immunotherapy with adoptive cytomegalovirus‐specific T cells transfer: Summarizing latest gene engineering techniques
by: Mahshid Mehdizadeh, et al.
Published: (2021-09-01)

Adoptivna celična terapija in limfociti T z izraženimi himernimi antigenskimi receptorji
by: Uroš Rajčević
Published: (2020-09-01)

Mechanisms of Neoantigen-Targeted Induction of Pyroptosis and Ferroptosis: From Basic Research to Clinical Applications
by: Jie Yu, et al.
Published: (2021-05-01)

Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies
by: Vitaly Chasov, et al.
Published: (2021-08-01)

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
by: Chittepu, V.C.S.R, et al.
Published: (2022)

Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy
by: Pavlina Chuntova, et al.
Published: (2019-01-01)

T-Cell Gene Therapy in Cancer Immunotherapy: Why It Is No Longer Just CARs on The Road
by: Michael D. Crowther, et al.
Published: (2020-06-01)

Microbiota: Overview and Implication in Immunotherapy-Based Cancer Treatments
by: Giovanni Brandi, et al.
Published: (2019-05-01)

New Orders to an Old Soldier: Optimizing NK Cells for Adoptive Immunotherapy in Hematology
by: Mehmet Gunduz, et al.
Published: (2021-09-01)

Immunotherapy with NK cells: recent developments in gene modification open up new avenues
by: Lisa Marie Reindl, et al.
Published: (2020-01-01)

Transplanters drive CARs to the clinic by brewing ICE-T: the Moffitt roadmap
by: Frederick L. Locke, et al.
Published: (2017-07-01)

Mechanisms of Resistance to NK Cell Immunotherapy
by: Christian Sordo-Bahamonde, et al.
Published: (2020-04-01)

Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors
by: Emre Balta, et al.
Published: (2021-05-01)

Design and Implementation of NK Cell-Based Immunotherapy to Overcome the Solid Tumor Microenvironment
by: Ishwar Navin, et al.
Published: (2020-12-01)

Hematopoietic stem cell‐ and induced pluripotent stem cell‐derived CAR‐NK cells as reliable cell‐based therapy solutions
by: Jonathan Arias, et al.
Published: (2021-07-01)

T Cell Epitope Prediction and Its Application to Immunotherapy
by: Anna-Lisa Schaap-Johansen, et al.
Published: (2021-09-01)

CAR-macrophage: A new immunotherapy candidate against solid tumors
by: Yizhao Chen, et al.
Published: (2021-07-01)

Tuning the performance of CAR T cell immunotherapies
by: Noah H. Richardson, et al.
Published: (2019-11-01)

Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways
by: Yan Yang, et al.
Published: (2020-09-01)

CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
by: Faroogh Marofi, et al.
Published: (2021-07-01)

CAR-NK Cells in the Treatment of Solid Tumors
by: Ewa Wrona, et al.
Published: (2021-05-01)

Editorial: Current Perspectives, Challenges and Advances in Cell Based Therapies
by: Monica S. Thakar, et al.
Published: (2020-02-01)

Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy
by: Faroogh Marofi, et al.
Published: (2021-03-01)

The promise of adoptive cellular immunotherapies in hepatocellular carcinoma
by: Peter G. Hendrickson, et al.
Published: (2020-01-01)

Engineered T Cell Therapy for Cancer in the Clinic
by: Lijun Zhao, et al.
Published: (2019-10-01)

Heat Shock Proteins in Lymphoma Immunotherapy
by: Zarema Albakova, et al.
Published: (2021-03-01)

Engineering Strategies to Enhance TCR-Based Adoptive T Cell Therapy
by: Jan A. Rath, et al.
Published: (2020-06-01)

CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
by: Seyed Mohammad Miri, et al.
Published: (2020-09-01)

The Ways of Isolating Neoantigen-Specific T Cells
by: Qing Li, et al.
Published: (2020-08-01)

Chimeric Antigen Receptor Cell Therapy: Overcoming Obstacles to Battle Cancer
by: Amy J. Petty, et al.
Published: (2020-03-01)

Efficient Pseudotyping of Different Retroviral Vectors Using a Novel, Codon-Optimized Gene for Chimeric GALV Envelope
by: Manuela Mirow, et al.
Published: (2021-07-01)

Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma
by: Rebecca C Abbott, et al.
Published: (2021-01-01)

The application of natural killer (NK) cell immunotherapy for the treatment of cancer
by: Rayne H Rouce, et al.
Published: (2015-11-01)

CART Immunotherapy: Development, Success, and Translation to Malignant Gliomas and Other Solid Tumors
by: Anna C. Filley, et al.
Published: (2018-10-01)

Cannot write session to /tmp/vufind_sessions/sess_h3904kn23o8k68d06s71jevjle